These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12885506)

  • 1. FDA says it will require trans-fat amounts on food labels.
    Ault A
    Lancet; 2003 Jul; 362(9379):218. PubMed ID: 12885506
    [No Abstract]   [Full Text] [Related]  

  • 2. Nutrition labels to reveal hidden, hazardous trans fats.
    Harv Heart Lett; 2002 Oct; 13(2):7. PubMed ID: 12393345
    [No Abstract]   [Full Text] [Related]  

  • 3. Coming soon: trans fat labeling.
    Health News; 2002 Sep; 8(9):6. PubMed ID: 12229901
    [No Abstract]   [Full Text] [Related]  

  • 4. Deception of trans fats on Food and Drug Administration food labels: a proposed revision to the presentation of trans fats on food labels.
    Brandt EJ
    Am J Health Promot; 2011; 25(3):157-8. PubMed ID: 21192743
    [No Abstract]   [Full Text] [Related]  

  • 5. The stealth fat.
    Consum Rep; 2003 Mar; 68(3):28-31. PubMed ID: 12599341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of trans fatty acid content in food, regulations and limits-the FDA view.
    Moss J
    Atheroscler Suppl; 2006 May; 7(2):57-9. PubMed ID: 16713387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanded use of 'lean' on food labels.
    FDA Consum; 2007; 41(2):6. PubMed ID: 17590896
    [No Abstract]   [Full Text] [Related]  

  • 8. Food labeling: trans fatty acids in nutrition labeling, nutrient content claims, and health claims. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jul; 68(133):41433-1506. PubMed ID: 12856667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How healthy are these fries?
    Gupta S
    Time; 2002 Sep; 160(12):85. PubMed ID: 12298148
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informing consumers about trans fat labeling.
    Stahl P
    J Am Diet Assoc; 2000 Oct; 100(10):1132, 1134. PubMed ID: 11183743
    [No Abstract]   [Full Text] [Related]  

  • 12. Trans fat bans and the human freedom: a refutation.
    Gostin LO
    Am J Bioeth; 2010 Mar; 10(3):33-4. PubMed ID: 20229413
    [No Abstract]   [Full Text] [Related]  

  • 13. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
    McNamara SH
    Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
    [No Abstract]   [Full Text] [Related]  

  • 14. Fessing up to fats.
    Kluger J
    Time; 2003 Jul; 162(3):52-3. PubMed ID: 14584336
    [No Abstract]   [Full Text] [Related]  

  • 15. Trans-fatty acids: a regulatory update.
    Dausch JG
    J Am Diet Assoc; 2002 Jan; 102(1):18, 20. PubMed ID: 11794493
    [No Abstract]   [Full Text] [Related]  

  • 16. Food labeling: nutrient content claims, expansion of the nutrient content claim "lean". Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jan; 72(8):1455-9. PubMed ID: 17294560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agency information collection activities; announcement of OMB approval; Food Labeling: Nutrition Labeling of Dietary Supplements on a "Per Day" Basis. Food and Drug Administration, HHS. Notice.
    Fed Regist; 1999 Mar; 64(57):14451. PubMed ID: 10558410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Food labeling: health claims and labeling statements; dietary fiber and cancer; antioxidant vitamins and cancer; omega-3 fatty acids and coronary heart disease; folate and neural tube defects; revocation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Oct; 65(192):58917-8. PubMed ID: 11503652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trans fats in New Zealand: time for labelling regulations?
    Gladding P; Benatar JR
    N Z Med J; 2007 Nov; 120(1265):U2801. PubMed ID: 18264181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current good manufacturing practice in manufacturing, packaging, labeling, or holding operations for dietary supplements. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2007 Jun; 72(121):34751-958. PubMed ID: 17674484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.